机构地区:[1]Department of Chemistry,TKL of Metal- and Molecule-based Material Chemistry,Key Laboratory of Advanced Energy Materials Chemistry (Ministry of Education),and Synergetic Innovation Center of Chemical Science and Engineering (Tianjin),Nankai University [2]Tianjin Institute of Pharmaceutical Sciences
出 处:《Chinese Journal of Structural Chemistry》2014年第1期97-103,共7页结构化学(英文)
基 金:Supported by the National Natural Science Foundation of China(21031002 and 51073079);the Fundamental Research Funds for the Central Universities;the Application and Research in Cutting-edge Technologies in Tianjin Technology Projects in General(K11JCYBJC11100)
摘 要:Two new Cu(II) coordination polymers, [Cu(FDA)(BPY)(H20)]n (1) and {[Cu(FDA)(BPY)(H2O)].2H2O}n (2) (H2FDA = 2,5-furandicarboxylic acid, BPY = 2,2'-bipyridine), have been synthesized and structurally characterized by single-crystal X-ray diffraction as well as elemental analysis and IR. Compound 1 crystallizes in monoclinic, space group P21/c, with a = 7.5915(15), b = 8.4050(17), c = 24.204(6) A, β = 99.05(3)°, V= 1525.1(6) A3, Dc = 1.706 g/crn3, C16HI2CuN206, Mr = 391.82, F(000) = 796, μ(MoKa) = 1.470 mm-l, Z = 4, R = 0.0633 and wR = 0.1059 for 2389 observed reflections (1 〉 2a(I)), R = 0.0738, and wR = 0.1098 for all data. Complex 2 belongs to triclinic space group PI with a = 8.8660(18), b = 8.9112(18), c = 12.525(3) A, a = 88.41(3), β = 69.38(3), γ = 66.95(3)°, V = 845.2(3) A3, Dc = 1.681 g/cm3, CI6HI6CuN2Os, Mr. = 427.85, F(000) = 438, μ(MoKα) = 1.342 mm-1, Z = 2, R = 0.0290 and wR = 0.0690 for 2767 observed reflections (I 〉 2σ(I)), R = 0.0329 and wR = 0.0706 for all data. Complexes 1 and 2 are both coordination polymers with one-dimensional chain structures bridged by the protonated FDA ligands, which are assembled into three-dimensional supramolecular structures through hydrogen bonding interactions and π-π packing interactions between the chains.Two new Cu(II) coordination polymers, [Cu(FDA)(BPY)(H20)]n (1) and {[Cu(FDA)(BPY)(H2O)].2H2O}n (2) (H2FDA = 2,5-furandicarboxylic acid, BPY = 2,2'-bipyridine), have been synthesized and structurally characterized by single-crystal X-ray diffraction as well as elemental analysis and IR. Compound 1 crystallizes in monoclinic, space group P21/c, with a = 7.5915(15), b = 8.4050(17), c = 24.204(6) A, β = 99.05(3)°, V= 1525.1(6) A3, Dc = 1.706 g/crn3, C16HI2CuN206, Mr = 391.82, F(000) = 796, μ(MoKa) = 1.470 mm-l, Z = 4, R = 0.0633 and wR = 0.1059 for 2389 observed reflections (1 〉 2a(I)), R = 0.0738, and wR = 0.1098 for all data. Complex 2 belongs to triclinic space group PI with a = 8.8660(18), b = 8.9112(18), c = 12.525(3) A, a = 88.41(3), β = 69.38(3), γ = 66.95(3)°, V = 845.2(3) A3, Dc = 1.681 g/cm3, CI6HI6CuN2Os, Mr. = 427.85, F(000) = 438, μ(MoKα) = 1.342 mm-1, Z = 2, R = 0.0290 and wR = 0.0690 for 2767 observed reflections (I 〉 2σ(I)), R = 0.0329 and wR = 0.0706 for all data. Complexes 1 and 2 are both coordination polymers with one-dimensional chain structures bridged by the protonated FDA ligands, which are assembled into three-dimensional supramolecular structures through hydrogen bonding interactions and π-π packing interactions between the chains.
关 键 词:2 5-furandicarboxylic acid copper complex crystal structure 2 2'-bipyridine
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...